Integration of multiscale entropy and BASED scale of electroencephalography after adrenocorticotropic hormone therapy predict relapse of infantile spasms
- PMID: 35906344
- DOI: 10.1007/s12519-022-00583-9
Integration of multiscale entropy and BASED scale of electroencephalography after adrenocorticotropic hormone therapy predict relapse of infantile spasms
Abstract
Background: Even though adrenocorticotropic hormone (ACTH) demonstrated powerful efficacy in the initially successful treatment of infantile spasms (IS), nearly half of patients have experienced a relapse. We sought to investigate whether features of electroencephalogram (EEG) predict relapse in those IS patients without structural brain abnormalities.
Methods: We retrospectively reviewed data from children with IS who achieved initial response after ACTH treatment, along with EEG recorded within the last two days of treatment. The recurrence of epileptic spasms following treatment was tracked for 12 months. Subjects were categorized as either non-relapse or relapse groups. General clinical and EEG recordings were collected, burden of amplitudes and epileptiform discharges (BASED) score and multiscale entropy (MSE) were carefully explored for cross-group comparisons.
Results: Forty-one patients were enrolled in the study, of which 26 (63.4%) experienced a relapse. The BASED score was significantly higher in the relapse group. MSE in the non-relapse group was significantly lower than the relapse group in the γ band but higher in the lower frequency range (δ, θ, α). Sensitivity and specificity were 85.71% and 92.31%, respectively, when combining MSE in the δ/γ frequency of the occipital region, plus BASED score were used to distinguish relapse from non-relapse groups.
Conclusions: BASED score and MSE of EEG after ACTH treatment could be used to predict relapse for IS patients without brain structural abnormalities. Patients with BASED score ≥ 3, MSE increased in higher frequency, and decreased in lower frequency had a high risk of relapse.
Keywords: Burden of amplitudes and epileptiform discharges score; Infantile spasms; Multiscale entropy; Prediction; Relapse.
© 2022. Children's Hospital, Zhejiang University School of Medicine.
Similar articles
-
Factors influencing efficacy and relapse of adrenocorticotropic hormone in infantile epileptic spasms syndrome.Epilepsy Behav. 2024 Dec;161:110055. doi: 10.1016/j.yebeh.2024.110055. Epub 2024 Sep 22. Epilepsy Behav. 2024. PMID: 39312843
-
Predictive factors for relapse of epileptic spasms after adrenocorticotropic hormone therapy in West syndrome.Brain Dev. 2016 Jan;38(1):32-9. doi: 10.1016/j.braindev.2015.05.012. Epub 2015 Nov 4. Brain Dev. 2016. PMID: 26547521
-
Long-term analysis of adrenocorticotropic hormone monotherapy for infantile epileptic spasms syndrome with periventricular leukomalacia.Seizure. 2023 Jul;109:40-44. doi: 10.1016/j.seizure.2023.05.012. Epub 2023 May 16. Seizure. 2023. PMID: 37207538
-
[Infantile spasms and West syndrome].Rev Med Chir Soc Med Nat Iasi. 2004 Jan-Mar;108(1):40-5. Rev Med Chir Soc Med Nat Iasi. 2004. PMID: 15688754 Review. Romanian.
-
Adrenocorticotropic hormone for the treatment of West Syndrome in children.Ann Pharmacother. 2013 May;47(5):744-54. doi: 10.1345/aph.1R535. Epub 2013 Apr 19. Ann Pharmacother. 2013. PMID: 23606552 Review.
Cited by
-
A novel nonlinear bispectrum analysis for dynamical complex oscillations.Cogn Neurodyn. 2024 Jun;18(3):1337-1357. doi: 10.1007/s11571-023-09953-z. Epub 2023 Mar 27. Cogn Neurodyn. 2024. PMID: 39534364 Free PMC article.
-
Neuronal complexity tracks changes of epileptic activity and identifies epilepsy patients independent of interictal epileptiform discharges.Epilepsia. 2025 Mar;66(3):790-801. doi: 10.1111/epi.18218. Epub 2024 Dec 12. Epilepsia. 2025. PMID: 39666315 Free PMC article.
-
Factors Influencing the Response of Patients with Infantile Epileptic Spasms Syndrome to ACTH as Repeated First-Line Therapy.Neurol Ther. 2025 Jun;14(3):759-774. doi: 10.1007/s40120-025-00722-0. Epub 2025 Mar 10. Neurol Ther. 2025. PMID: 40063195 Free PMC article.
References
-
- O’Callaghan FJK, Edwards SW, Alber FD, Cortina Borja M, Hancock E, Johnson AL, et al. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial. Lancet Child Adolesc Health. 2018;2:715–25. - PubMed - DOI
-
- Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms. Cochrane Database Syst Rev. 2013;6:CD001770. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources